difference between unictam and augmentin and their uses

difference between unictam and augmentin and their uses in treating bacterial infections affecting the respiratory tract, urinary tract, and skin infections, they are among the best antibiotics used to treat bacterial infections and prevent severe viral infections. They are also effective in treating sore throats, tonsillitis, and bronchitis. We will learn about the differences between each of them, their mechanism of action, recommended dosages, and all relevant information about the two medications.

Unictam Ingredients

It consists of the following active ingredients:

• Sulbactam, a substance that works to inhibit the beta-lactamase enzyme produced by bacteria to break down antibiotics. This helps reduce bacterial activity and thus enhances the antibiotic's effectiveness in killing bacteria.
• Ampicillin, an antibiotic that works to kill disease-causing bacteria.

Augmentin Tablets Ingredients

It contains the following active ingredients:

• Amoxicillin, a substance that inhibits the formation of bacterial cell walls and helps eliminate the bacteria that cause infection.
• Clavulanic acid, which enhances the effectiveness of amoxicillin in eliminating bacterial infections in the body.

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 17 August 2025